DiscoverThe Carlat Psychiatry PodcastCobenfy: A New Antipsychotic
Cobenfy: A New Antipsychotic

Cobenfy: A New Antipsychotic

Update: 2024-10-07
Share

Description

KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.


CME: Take the CME Post-Test for this Episode

Published On: 10/07/2024

Duration: 12 minutes, 28 seconds


Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cobenfy: A New Antipsychotic

Cobenfy: A New Antipsychotic

Pocket Psychiatry: A Carlat Podcast

We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and our services, you agree to our use of cookies as described in our Cookie Policy.